OneMedNet Corporation (ONMD)
| Market Cap | 26.88M -75.3% |
| Revenue (ttm) | 1.46M +217.0% |
| Net Income | -8.43M |
| EPS | -1.53 |
| Shares Out | 6.01M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,521 |
| Open | 4.790 |
| Previous Close | 4.710 |
| Day's Range | 4.350 - 4.790 |
| 52-Week Range | 3.610 - 24.600 |
| Beta | 1.15 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About ONMD
OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. It offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets. The company also provides BEAM, a medical imaging exchange platform between hospital/healthcare systems, imaging centers, physicians, and patients. OneMedNet Corporation is headquartered... [Read more]
Financial Performance
In 2025, OneMedNet's revenue was $1.36 million, an increase of 111.35% compared to the previous year's $643,000. Losses were -$2.80 million, -72.35% less than in 2024.
Financial StatementsNews
OneMedNet announces channel partner agreement
OneMedNet (ONMD) announced a channel partner agreement with a provider of pharmaceutical intelligence and data solutions will distribute OneMedNet’s U.S.-sourced, de-identified clinical data to its es...
OneMedNet Signs Global Pharmaceutical Intelligence Provider as Channel Partner, Extending Reach in Pharma Market
MINNEAPOLIS, Oct. 19, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory...
OneMedNet Adds Leading Hospital System Provider Network, Expanding By Up to 12 Hospitals
MINNEAPOLIS, Oct. 15, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory...
OneMedNet announces eleventh channel partner agreement with Mediplexus
OneMedNet (ONMD) announced its eleventh channel partner agreement with Mediplexus. Under the agreement, OneMedNet will supply its U.S.-sourced Real World Data to Mediplexus, its appointed distributor ...
OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company's Real World Data Footprint into Korea and the Asia Pacific Region
MINNEAPOLIS, Oct. 07, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory...
OneMedNet signs seven figure multiyear agreement to power data solution
OneMedNet (ONMD) announced a seven figure multiyear agreement to deliver de-identified, multimodal, longitudinal clinical Real World Data to a commercially scaled AI-enabled precision medicine company...
OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution
MINNEAPOLIS, Sept. 30, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet," the "Company," "we," "us" or "our"), a leading provider of First-Party (Direct-from-Source) regulator...
Onemednet Corp trading halted, news pending
19:50 EDT Onemednet (ONMD) Corp trading halted, news pending
OneMedNet announces 1-for-10 reverse stock split
OneMedNet (ONMD) Corporation will implement a 1-for-10 reverse stock split of its issued and outstanding shares of common stock effective at 12:01 a.m. Eastern Time on September 29. The Reverse…
OneMedNet Corporation Announces 1-for-10 Reverse Stock Split
MINNEAPOLIS, Sept. 25, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “Company,” “we,” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, ...
Atropos Health Scales Federated Evidence Network with Multimodal Data Partners to Accelerate Health Analytics and AI Model Development
PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, a leader in real-world evidence (RWE) generation from high-quality healthcare data, today announced a significant expansion of its federated Atropos...
OneMedNet announces strategic partnership with Atropos Health
OneMedNet (ONMD) announced a strategic partnership with Atropos Health. The partnership adds OneMedNet’s regulatory decision-grade data to Atropos’ platform and customer offerings under a fee arrangem...
OneMedNet Expands Commercial Reach Through Multi-Year Resale Agreement with Atropos Health
MINNEAPOLIS, Sept. 22, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us,” or “our”), a leading provider of regulatory decision-grade, AI-driven Real...
OneMedNet Transcript: AGM 2026
The meeting approved all four proposals, including director elections, auditor ratification, an equity plan amendment, and a reverse stock split. Over 70% of shares were represented, and final voting results will be filed with the SEC.
OneMedNet announces year-to-date bookings of $16.2M
OneMedNet (ONMD) announced year-to-date bookings of approximately $16.2M, a 16X increase versus the same period in 2025. A significant portion of these bookings are expected to be delivered during the...
OneMedNet Reports Record Bookings as Faster Fulfillment Begins
MINNEAPOLIS, Sept. 18, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of first-party (direct-from-source) regulator...
OneMedNet's iRWD Platform Enables Rapid Feasibility-to-Delivery for Leading AI-Driven Drug Development Company
MINNEAPOLIS, Aug. 31, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of first-party (direct-from-source) regulatory...
OneMedNet Proxy statement: Proxy filing
OneMedNet filed a proxy statement on August 19, 2026, providing details for shareholder voting and corporate governance matters.
OneMedNet Quarterly report: Q2 2026
OneMedNet has published its Q2 2026 quarterly earnings report on August 14, 2026.
OneMedNet Proxy statement: Proxy filing
OneMedNet filed a proxy statement on August 7, 2026, providing details for shareholder voting and corporate governance matters.
OneMedNet enters $11.5M pact to supply iRWD platform data
OneMedNet (ONMD) announced it has entered into an agreement to supply its regulatory-grade, multi-modal imaging-centric iRWD platform data for use in the development and training of a foundational AI ...
OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development
MINNEAPOLIS, July 28, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-driven Real-W...
OneMedNet Registration statement: Registration filing
OneMedNet filed a registration statement on July 8, 2026, providing details about a securities offering with the SEC.
OneMedNet files to sell 11.68M shares of common stock for holders
17:34 EDT OneMedNet (ONMD) files to sell 11.68M shares of common stock for holders
OneMedNet Registration statement: Registration filing
OneMedNet filed a registration statement on July 1, 2026, providing details about a securities offering with the SEC.